Hillsdale Investment Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-226,400	Closed	-$4.6M	–	581
2022 Q4	$4.6M	Buy	226,400 +1,000	+0.4%	+$25.1K	0.39%	93
2022 Q3	$5.78M	Sell	225,400 -23,600	-9%	-$632K	0.52%	46
2022 Q2	$5.92M	Buy	249,000 +1,400	+0.6%	+$30.5K	0.47%	48
2022 Q1	$5.58M	Buy	+247,600	New	+$5.27M	0.36%	88
2020 Q4	–	Sell	-185,400	Closed	-$3.23M	–	602
2020 Q3	$3.23M	Hold	185,400	–	–	0.32%	95
2020 Q2	$3.12M	Buy	+185,400	New	+$2.6M	0.28%	105
2018 Q2	–	Sell	-80,300	Closed	-$1.32M	–	503
2018 Q1	$1.32M	Sell	80,300 -10,000	-11%	-$185K	0.18%	99
2017 Q4	$1.63M	Hold	90,300	–	–	0.26%	58
2017 Q3	$1.74M	Hold	90,300	–	–	0.29%	51
2017 Q2	$1.07M	Sell	90,300 -13,000	-13%	-$141K	0.21%	93
2017 Q1	$1.13M	Buy	+103,300	New	+$907K	0.22%	83